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Abstract: Since its emergence in the 1990s, White Spot Disease (WSD) has had major economic
and societal impact in the crustacean aquaculture sector. Over the years shrimp farming alone has
experienced billion dollar losses through WSD. The disease is caused by the White Spot Syndrome
Virus (WSSV), a large dsDNA virus and the only member of the Nimaviridae family. Susceptibility
to WSSV in a wide range of crustacean hosts makes it a major risk factor in the translocation of live
animals and in commodity products. Currently there are no effective treatments for this disease.
Understanding the molecular basis of disease processes has contributed significantly to the treatment
of many human and animal pathogens, and with a similar aim considerable efforts have been directed
towards understanding host–pathogen molecular interactions for WSD. Work on the molecular
mechanisms of pathogenesis in aquatic crustaceans has been restricted by a lack of sequenced and
annotated genomes for host species. Nevertheless, some of the key host–pathogen interactions have
been established: between viral envelope proteins and host cell receptors at initiation of infection,
involvement of various immune system pathways in response to WSSV, and the roles of various
host and virus miRNAs in mitigation or progression of disease. Despite these advances, many
fundamental knowledge gaps remain; for example, the roles of the majority of WSSV proteins are
still unknown. In this review we assess current knowledge of how WSSV infects and replicates in its
host, and critique strategies for WSD treatment.
Keywords: White Spot Syndrome Virus; host–pathogen interactions; viral infection pathway;
endocytosis; stress responses; apoptosis; treatments; miRNA
1. Introduction
Since its emergence in the early 1990s, White Spot Disease (WSD) has become the greatest threat
to global crustacean aquaculture industries [1]. The first case of WSD was reported in China in 1991 [2]
and this was followed by spread to other major aquaculture regions of the world including East and
Southeast Asia, the Americas, India, the Middle East [2–7], and even Europe [8]. The total economic
damage caused by WSD to the shrimp aquaculture industry has been estimated at $8–$15 billion since
its emergence [9], increasing by $1 billion annually [10,11]. Annual losses have traditionally equated
to approximately one tenth of global shrimp production [11]. A wide range of other crustacean hosts
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are susceptible to WSSV infection and disease. Natural populations of these hosts can also act as
reservoirs for this pathogen [11,12]. Given the scale of WSD in captive crustaceans, it is not surprising
that considerable scientific effort has been directed towards establishing the underlying mechanisms
of the disease and identifying potential treatments for disease prevention or alleviation. However,
despite a growing knowledge base and research interest, to date cost-effective vaccinations and/or
treatments remain elusive.
WSD is caused by White spot syndrome virus (WSSV) [13], a double-stranded DNA virus and the
only member of the genus Whispovirus and family Nimaviridae [14,15]. WSSV was originally classified
as member of the Baculoviridae family, but it was later reclassified and named White Spot Syndrome
Virus 1 by the International Committee on Taxonomy of Viruses ICTV [14–17]. The Whispovirus is
a newly recognized family and its membership is likely to increase in the future as new taxa are
discovered [17]. Vlak et al. [17] tentatively list B virus, B2 virus, τ (tau) virus, and Baculo-A and
Baculo-B viruses as putative members of the Whispovirus genus and Nimaviridae family.
Animals suffering from WSD display various clinical signs including lethargy, reduced food
consumption, reduced preening activities, a loosening of the cuticle, and a discoloration of the
hepatopancreas [18,19]. White calcified spots appearing on the exoskeleton are diagnostic of WSD
in some [19] but not all host species (e.g., the Indian prawn (Penaeus indicus) [20]). In farmed shrimp
mortality is rapid and 3–10 days after infection cumulative mortality is generally between 90% and
100% [6,21].
WSSV infection occurs in all tissues of mesodermal and ectodermal origin (e.g., gills, lymphoid
organ, cuticular epithelium, sub-cuticular connective tissues). Infected nuclei become hypertrophied
with marginalized chromatin, and contain inclusion bodies that stain intensely eosinophillic in
early-stage infection and basophilic in more advanced infection (Figure 1) [22]. Morphologically, WSSV
virions are large and rod-shaped with dimensions in the range of 80–120 ˆ 250–380 nm [13,23,24].
Structurally, they have a nucleocapsid surrounded by a trilaminar envelope [23] with a tail-like
appendage, the function of which is unknown [13,23].
Economic drivers have focused research on WSD in farmed shrimp; however, the host range
of WSSV includes many other decapod and non-decapod species including crabs, lobsters, prawns,
crayfishes, and copepods [18,25]. To date 98 potential host species for WSD have been identified [2].
It is also the case that many organisms living in a WSSV-infected pond can function as a vector for
WSSV [2]. Although WSD causes high levels of mortality in all cultured shrimps, it is not necessarily
fatal to other hosts [26]. Variation in disease susceptibility occurs across the Crustacea and this is
of particular interest as it may provide insights into disease resistance [3,27–36]. The shore crab
(Carcinus maenas), for instance, while confirmed as susceptible to infection, appears to be especially
recalcitrant to development of disease, showing little pathology and low mortality rates [36].
WSSV can be transmitted through the consumption of infected tissue, by cannibalism/predation,
and via exposure to water containing WSSV virions [37,38]. Transmission through ingestion
of contaminated prey tends to be the most effective path for infection of these two exposure
routes [18,39]. A comparison between Asian tiger shrimp (Penaeus monodon) and Whiteleg shrimp
(Litopenaeus vannamei) has shown that overall transmission rates are similar in these species but the
relative contributions of direct and indirect transmission rates differ [40]. Transmission through
physical contact with an infected animal is sufficient to initiate and progress WSD epidemics in
ponds [40]. Vertical transmission (parents to progeny) of WSSV has been suggested and WSSV
particles have been identified in oocytes. However, WSSV particles appear to be absent in mature
eggs, suggesting that oocytes that contain the virus do not develop to mature eggs [18]. Vertical
transmission might therefore occur through ingestion of viral particles that have been shed by adults
during spawning into larval stages [18,37,41]. Virus pathogenicity can also be affected as it passes
between species. As an example, WSSV, when passed through Macrobrachium rosenbergii, had a reduced
pathogenicity (reduced mortality rates) in P. monodon when compared to non-transmitted virus. How
this change in pathogenicity is mediated has not been established but was shown to be accompanied
Viruses 2016, 8, 23 3 of 29
by variations in tandem repeat regions in the WSSV genome [42]. When considering transmission of
WSSV between different geographical locations there is good evidence that this is facilitated by the
transport of live and frozen uncooked shrimp [43,44] and the import of brood stock [11].
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Figure 1. White Spot Syndrome Virus (WSSV) infection of Litopenaeus vannamei. The infection 
progresses through different stages that can be seen in the nucleus via histology. (A) Early-stage 
infected cells display enlarged nuclei with marginalized chromatin and a homogenous eosinophilic 
central region. These then develop an intranuclear eosinophilic Cowdry A-type inclusion (*); this can 
be surrounded by a clear halo beneath the nuclear membrane (white arrow). Scale bar = 25 µm; (B) 
The eosinophilic inclusion usually expands to fill the nucleus (*). This inclusion becomes basophilic 
in staining and denser in color as the infection progresses (white arrow). Nuclei then disintegrate so 
that the content fuses with the cytoplasm (black arrow). Scale bar = 10 µm. H&E stain; (C) WSSV 
virions appear ovoid in shape and contain an electron-dense nucleocapsid (white arrow) within a 
trilaminar envelope (black arrow). Scale bar = 0.2 µm. Inset. Negatively stained WSSV nucleocapsid, 
showing the presence of cross-hatched or striated material that is structured as a series of stacked 
rings of subunits and is a key diagnostic feature of WSSV. Scale bar = 20 nm; (D) Presumptive 
nucleocapsid material within the nucleus prior to envelopment. This material is cross-hatched or 
striated in appearance and linear prior to its incorporation in the formation of mature WSSV particles. 
This linear nucleocapsid material is observed sporadically in the manufacture of the WSSV particles. 
Scale bar = 100 nm. Transmission electron microscopy images. 
Prevention or treatment strategies for WSD disease could be advanced through an 
understanding of how this virus infects organisms and/or how relatively resistant animals process 
WSSV during the infection process. This requires understanding of the (molecular) interactions 
between WSSV and its potential hosts. In the infection process, WSSV invades host cells and initiates 
replication of its components. This is followed by assembly and release of new virions, resulting in 
host cell death and disease. To prevent disease, hosts must recognize the invading pathogen and elicit 
appropriate defense strategies or create a cellular environment that is not appropriate for production 
of new virions. A number of review articles have been published detailing the interactions between 
viruses and the host innate immune system (Li et al. [45], Shekhar and Ponniah [46], Sanchez-Paz [47], 
and Sritunyalucksana et al. [48]) but the interactions between WSSV and the host intracellular 
environment have received less attention. This is fundamental for advancing our understanding of 
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Prevention or treatment strategies for WSD disease could be advanced through an understanding
of how this virus infects organisms and/or how relatively resistant animals process WSSV during
the infection process. This requires understanding of the (molecular) interactions between WSSV and
its potential hosts. In the infection process, WSSV invades host cells and initiates replication of its
components. This is followed by assembly and release of new virions, resulting in host cell death
and disease. To prevent disease, hosts must recognize the invading pathogen and elicit appropriate
defense strategies or create a cellular environment that is not appropriate for production of new
virions. A number of review articles have been published detailing the interactions between viruses
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and the host innate immune system (Li et al. [45], Shekhar and Ponniah [46], Sanchez-Paz [47], and
Sritunyalucksana et al. [48]) but the interactions between WSSV and the host intracellular environment
have received less attention. This is fundamental for advancing our understanding of the WSD
infection process and exploring potential opportunities for disease treatment and prevention. In this
review, we analyze the current knowledge on the WSSV genome, with a focus on the molecular
mechanisms that enable WSSV to interact with host machinery and maintain a cellular environment
favorable for the production of new virions. We then investigate the current treatment options that have
been explored and consider possible future directions for advancing disease treatment and mitigation.
2. The WSSV Genome and miRNAS
2.1. WSSV Genome
WSSV contains a circular dsDNA genome of approximately 300 kb in size. Genome sequences for
four WSSV isolates are available (a Chinese isolate (WSSV-CN; GenBank Accession AF332093) [49],
an isolate from Thailand (WSSV-TH; GenBank Accession AF369029) [16], a Taiwanese isolate
(WSSV-TW; GenBank Accession AF440570), and a Korean isolate (WSSV-KR; GenBank Accession
JX515788) [50]). They differ in size, indicating some degree of genomic instability: (293 kb (Thailand),
296 kb (Korea), 305 kb (China), and 307 kb (Taiwan)). Overall, the sequence identity between isolates
ranges between 97% and 99%, and the GC content in all isolates is 41% [50]. The WSSV genome contains
nine homologous regions (hr 1–9) consisting of several repeats of 250–300 bp fragments, encompassing
direct repeats, atypical inverted repeat sequences, and imperfect palindromic sequences [16]. Such hr
regions in the genomes of baculoviruses have been hypothesized to play a part in DNA replication [51].
Several important genetic variations have been identified between the genomes of the Thai,
Taiwanese, and Chinese isolates [51]. The largest involves a deletion of approximately 13 kb (WSSV-TH)
and 1 kb (WSSV-CN), in the same genomic region, relative to WSSV-TW [51]. A region of approximately
750 bp shows variation between WSSV-TH and WSSV-TW, but the sequence of this region has no
homology to sequences in publically available databases. Another variation includes a 1337 bp insert
in WSSV-TH that shows 100% homology with a known transposable element [51]. Variable number
tandem repeats (VNTR) are present amongst four hrs: hr1, hr8, hr3 and hr9. VNTRs occur in open
reading frames (ORF), e.g., ORF75, ORF94 and ORF125 in WSSV-TH, and have been suggested for
use in genotyping WSSV [51,52]. Sequence variations have been shown to be stable over at least
six passages through three different penaeid shrimp species [52]. Smaller variations like single
nucleotide polymorphisms and short insertions/deletions are found throughout the WSSV genome [47].
The effects of genetic variation on WSSV virulence and fitness have been investigated in a number of
studies, which have demonstrated higher virulence and competitive fitness in isolates with smaller
genomes [53].
Putative ORFs in the WSSV genome have been determined for every isolate. These ORFs are
present on both strands (~54% forward and ~46% reverse [16,50]), and the total number of estimated
ORFs in the different isolates are 532 for WSSV-TW, 515 for WSSV-KR, 531 for WSSV-CN, and 684 for
WSSV-TH. The nomenclature of ORFs differs in GenBank; for reference the conventions are as follows:
WSSV-TW = WSSVxxx, WSSV-KR = wssv_xxxxx, WSSV-CN = wsvxxx and WSSV-TH = ORFxxx. The
number of expressed ORFs is difficult to determine since many do not show homology with known
protein sequences. Estimates are based on the potential to code for proteins of at least 50–60 amino
acids. Functional predictions based on sequence similarity and protein motifs indicate that around
180 ORFs are likely to be expressed [16,49]. Microarrays constructed based on 184 putative ORFs
of WSSV-TH confirmed expression of 79% of these ORFs in the gills of P. monodon infected with
WSSV [54]. An analysis of the codons of ORFs (>100 codons) in WSSV-TW, WSSV-CN, and WSSV-TH
indicated that codon usage bias and base composition are determined by compositional limitations
and mutational pressure [55]. Interesting features of WSSV ORFs include one exceptionally long
ORF—the longest among all viruses, specifically wssv_03600—which is 18,221 bp in the Korean isolate.
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Its protein product, VP664, is a major structural protein that forms the stacked rings of the WSSV
nucleocapsid [16,50,56–58]. Furthermore, only around 30% of the ORFs in the WSSV genome contain a
polyadenylation signal. ORFs without polyadenylation signals are usually part of a cluster of ORFs
with small intergenic regions and identical transcriptional orientation that can produce polycistronic
mRNAs (e.g., the vp60b/wssv478/wssv479/vp28 cluster) [59–62]. Translation from these polycistronic
mRNAs is likely to be facilitated by internal ribosome entry sites (IRES) [62,63]. Several IRES have
been identified thus far including in the 51 UTR of wssv480 (vp28) [64], in the coding regions of wssv396
(vp31) and wssv395 (vp39b) [63], and in the 51 UTR of icp35 [62]. Translation initiation through IRES
enables viral protein production even under unfavorable conditions such as during host response to
viral infection, therefore making the virus more robust to host interference [63,65].
2.2. miRNAs, WSSV Infection, and Pathogenesis
MiRNAs (small non-coding RNA molecules) have been documented to be widely expressed
in both animal and plant species, and have key regulatory roles in a number of cellular pathways,
including early development, cell differentiation and proliferation, apoptosis, signal transduction, and
immunity [66].
It is now well established that miRNAs are involved in many host–pathogen interactions,
as reviewed in Asgari 2011 and Skalsky et al. 2010 [67,68]. The primary function of miRNAs
involves regulation of gene expression at the post-transcriptional level. Typically, miRNAs bind
to complementary sequences (either partial or complete) in the mRNA of target genes, regulating
gene expression by repressing translation or directing sequence-specific degradation of the mRNA.
However, evidence has also emerged that interaction of miRNAs with target genes may also function
to induce gene expression [69–71]. MiRNAs encoded in a virus genome may function to regulate
either viral or host genes to manipulate immune responses and cellular functions for the benefit of the
virus. Additionally, viruses may regulate and use host miRNAs to facilitate their own replication or to
regulate the virus life cycle [72,73]. Alternatively, host miRNAs can act to limit viral replication or alter
cellular processes to the disadvantage of the virus [68,74].
In WSSV-challenged shrimp (M. japonicus) 63 host miRNAs have been identified through small
RNA sequencing, of which 48 could be mapped to other known arthropod miRNAs in the miRBase
database [75]. Thirty-one of the miRNAs show differential expression in response to WSSV infection.
Using target gene prediction algorithms, many of the miRNAs were predicted to target genes involved
in host immunity, including the small GTPase-mediated signaling transduction pathway, autophagy,
phagocytosis, apoptosis, the Toll-like receptor signal pathway, antimicrobial humoral response,
endocytosis, RNAi, and regulation of the innate immune response. Huang and Zhang [76] showed
a more direct interaction between host miRNA and WSSV: a miRNA found to be upregulated in
WSSV-infected M. japonicus, miR-7, was predicted to target the 31-untranslated region of wsv477.
In insect High Five cells, the expression of enhanced green fluorescent protein (EGFP) was dramatically
reduced when coupled to the wsv477 31UTR compared to controls [76]. Wsv477 is an early gene that is
involved in viral gene replication. Its inhibition would thus have negative effects on WSSV replication.
Indeed, injection of miR-7 was shown to reduce WSSV copies 1000-fold compared with WSSV only at
72 and 96 h post-infection [76].
The specific viral miRNAs encoded by WSSV have been investigated in M. japonicus [77,78].
In the first study on these miRNAs in M. japonicus, WSSV was shown to have the capacity to encode
40 distinct miRNAs, which is a miRNA density 360 times greater than in humans [77]. The authors
of that work suggested that this high miRNA content may contribute to the ability of viruses to
respond rapidly to selective pressures placed on them from the host organism. In this study miRNAs
were first predicted through bioinformatic analyses and subsequently their presence was confirmed
through expression (microarray) studies and Northern blots. Subsequent work applying small RNA
sequencing identified additional WSSV miRNAs [78], bringing the total number of WSSV miRNAs
collectively to 89 [78]. It was observed that the majority of the miRNAs were expressed during the
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early stages of infection and that host genes like Drosha, Dicer1, and Ago1 are necessary for successful
miRNA biogenesis [77,78]. Interestingly, several miRNAs showed differential expression across tissue
types, indicating that viral regulatory strategies could be regulated to fit the infected tissue type [78].
One example of this regulatory effect was the potential of WSSV-miR-N24 to inhibit apoptosis through
downregulation of caspase 8 expression [78]. WSSV miRNAs can also regulate the balance between
promotion of viral infection and latency. He et al. [79] identified two WSSV miRNAs, WSSV-miR-66
and WSSV-miR-68, that promote WSSV infection through regulating expression of WSSV genes. It is
hypothesized that the targets of these miRNAs, wsv094 and wsv177 (WSSV-miR-66), and wsv248 and
wsv309 (WSSV-miR-68), are related to latency. These studies provide key evidence that WSSV miRNAs
function as regulatory factors involved in the virus life cycle as well as the host immune response.
3. WSSV Infection
The life cycle of viruses is well studied, and can be broadly divided into three phases: entry
into the host cell (either directly or through host mechanisms such as endocytosis), uncoating of the
genome followed by replication, and, finally, particle assembly and release. A model for the WSSV life
cycle and morphogenesis was suggested by Escobedo-Bonilla and colleagues [80]. Throughout these
phases a wide range of molecular interactions occur between the WSSV and its host (see Figure 2).
These molecular interactions can be key factors in determining host susceptibility and pathogenicity,
and also provide opportunities for treatment interventions.
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Figure 2. Overview of WSSV entry and environment interactions. Top panel: Viral entry into the
host cell. WSSV proteins interact with host receptors, which leads to induction of Clathrin-mediated
endocytosis. WSSV then travels through endosomes. During maturation the pH decreases, a cue
for viruses to exit th endosomes. This stage robably involves an interaction be ween VP28 and
Rab7. H w WSSV passes through the nuclear e velop is unk wn. Once in the nucleus, host
transcription factors bind the WSSV genome (e.g., ie1) and initiate expression of viral genes. Bottom
panel: Intracellular interactions between WSSV and the host cell. WSSV DNA replication requires host
machinery (e.g., processivity factors) and to make these available WSSV can act to halt the cell cycle in
the S-phase through E2F1. A high level of viral protein production can lead to ER stress, e.g., activation
of unfolded protein response (UPR) pathways. Transcription factors of the UPR can activate expression
of viral genes, which in turn may inhibit translation through eIF2. WSSV replication requires essential
nutrients including iron. To prevent the host from withholding iron, WSSV can inhibit the binding of
iron to F rritin. WSSV can influence apoptosis signaling either through miRNA-mediated inhibition of
initiator caspases or through viral proteins that inhibit effector caspase activity.
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3.1. Viral Receptors, Interactions, and Entry
The primary obstacle for entry into host cells is the host’s cell membrane. Viruses have evolved
several methods to overcome this barrier including via lipid fusion and membrane perforation,
but they enter the host cell predominantly by endocytosis [81]. In the latter case viruses bind
with host cell surface proteins, carbohydrates, and lipids [81], which then trigger one of the
various endocytic pathways including Clathrin-mediated endocytosis, caveolar endocytosis, and
macropinocytosis [81–84]. WSSV enters the host cell through activating the endocytotic process
with protein interactions. Known interacting elements for WSSV and its hosts are presented in
Table 1. It can be seen that VP28, the major envelope protein, is a major player in host–virus protein
interactions [85–88]. Some interactions are beneficial for the virus; others have negative impacts. There
is also a series of interacting proteins for which the functions are not well established.
Table 1. Established WSSV–host protein interactions.
Viral Protein Host Protein Species Reference
VP24, VP32, VP39B,
VP41A, VP51B, VP53A,
VP53B, VP60A, VP110,
VP124, VP337
Chitin-binding protein
(PmCBP) Penaeus monodon [89,90]
VP53A Glut1 P. monodon [91]
VP15, VP26, VP28 gC1qR (PlgC1qR) Pacifastacus leniusculus [92]
VP95, VP28, VP26, VP24,
VP19, VP14 C-type lectin (LvCTL1) Litopenaeus vannamei [93]
VP28 C-type lectin (FcLec3) Fenneropenaeus chinensis [94]
VP26, VP28 C-type lectins (MjLecA,MjLecB, MjLecC) Marsupenaeus japonicus [95]
VP28 C-type lectins (MjsvCL) M. japonicus [96]
VP28 C-type lectins (LdlrLec1,LdlrLec2) M. japonicus [97]
VP187 β-Integrin
P. japonicus
[98]
P. clarkii
VP26, VP31, VP37, VP90,
VP136 β-Integrin L. vannamei [99]
WSSV-CLP α-integrin, β-integrin,Syndecan F. chinensis
[100] (Bioinformatic
prediction)
VP15, VP28 Calreticulin (PlCRT) P. leniusculus [101]
VP466 Rab (PjRab) P. japonicus [102]
VP28 Rab7 (PmRab7) P. monodon [103]
ORF514 PCNA (lvPCNA) L. vannamei [104] (Bioinformaticprediction)
WSSV PK1 Ferritin (lvFerritin) L. vannamei [105]
Wsv083 FAK (MjFAK) M. japonicus [106]
AAP1 (WSSV449) Caspase (PmCaspase) P. monodon [107]
WSSV134, WSSV332 Caspase (PmCasp) P. monodon [108]
WSSV249 Ubc (PvUbc) L. vannamei [109]
ICP11 Histones P. monodon [110]
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Table 1. Cont.
Viral Protein Host Protein Species Reference
VP9 RACK1 (PmRACK1) P. monodon [111]
VP15 FKBP46 (PmFKBP46) P. monodon [112]
VP15 CRT (PlgCRT) P. leniusculus [101]
WSSV-miRNA Dorsha, Dicer, Ago1 – [77]
VP14 Arginine kinase (LvAK) L. vannamei [113]
VP26 Actin Procambarus clarkii [114]
ORF427 PPs L. vannamei [115]
WSSV IE1 TATA box-bindingprotein (PmTBP) P. monodon [116]
WSSV IE1, WSV056 Retinoblastoma protein(Lv-RBL) L. vannamei [117]
Integrin receptors on host cell surfaces have been shown to be important targets for WSSV.
Principally involved in the binding of cells to the extracellular matrix (or cell–cell adhesion), integrins
are heterodimeric surface receptors that recognize Arg-Gly-Asp (RGD) motifs in target proteins [118].
Several WSSV proteins can bind to α- or β-integrin homologues. Immunoprecipitation experiments
have shown binding of β-integrin by VP187 (wsv209), a viral protein that contains an RGD motif [98].
This body of work also found that WSSV infection could be blocked by soluble integrin, integrin-specific
antibody, an RGD-containing peptide, and silencing of β-integrin, indicating an important role for
integrins as WSSV receptors [98]. The viral proteins VP26, VP31, VP37, VP90 and VP136 also interact
with the integrin receptors of L. vannamei, mainly through interactions with RGD-, YGL-, and LDV
peptide motifs present in these viral proteins [99]. VP26 is a tegument protein that associates with a
protein complex involving VP24, VP28, VP38A, VP51A, and WSV010 in the viral envelope [57,119].
Since VP26 is not present on the cell exterior it is unlikely to play a role in binding host cells. Finally,
bioinformatics analyses have predicted that WSSV collagen-like protein (WSSV-CLP) interacts with
integrins on the basis of sequence similarity to known interacting protein pairs [100]. Together, these
studies show that multiple proteins are involved in the recognition and binding of host integrins [99].
In P. monodon, the cell surface Chitin-binding protein (PmCBP) has been shown to bind to 11 WSSV
proteins that likely form a complex on the surface of WSSV (VP24, VP110, VP53A, VP53B, VP337, VP32,
VP124, VP41A, VP51B, VP60A, and VP39B) [90]. Facilitating viral entry through protein complex
interactions also occurs for other enveloped DNA viruses (e.g., Herpesviridae [120]). Interactions of
the viral protein complex with PmCBP and with VP53A appear to be facilitated by glucose transporter1
(Glut1) [91].
The innate immune system of the host employs groups of proteins that are able to recognize
and bind pathogen-associated molecular patterns (PAMP) molecules. One family of proteins that
recognizes non-self molecules are the lectins. Calcium-dependent lectins (C-type lectins) have been
demonstrated to interact with WSSV proteins. Several interactions between host C-type lectins and
WSSV proteins have been identified (see Table 1), including a C-type lectin in L. vannamei (LvCTL1)
that can interact with VP95, VP28, VP26, VP24, VP19, and VP14 [93]. Treating WSSV with recombinant
LvCTL1 prior to a shrimp WSSV exposure was shown to result in higher survival rates, indicating a
protective effect [93]. Lectins from other shrimp species have shown interactions with VP26 and VP28.
For example, in the Chinese white shrimp (F. chinensis) a lectin (FcLec3) has been identified that can
interact with VP28 [94]. Using VP26, VP28, and VP281 to screen a phage display library of M. japonicus,
three lectins (MjLecA, MjLecB, and MjLecC) were identified to interact with the viral proteins [95].
Of these, MjLecA and MjLecB were shown to reduce viral infection rate in vitro [95]. Interactions with
other lectins found in M. japonicus indicate a contradictory relationship between WSSV and lectins.
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For example, a C-type lectin isolated from the stomach of M. japonicus (MjsvCL) has been shown to
interact with VP28 [96] but, in contrast to other lectins, MjsvCL appears to facilitate WSSV infection.
MjsvCL expression is induced by viral infection, and inhibition of its expression by RNAi results in
lower virus replication, whereas exogenous MjsvCL enhances replication [96]. MjsvCL contributes to
viral entry by binding of VP28 and the calreticulin receptor on the cell surface. MjsvCL thus works as
a bridge between the virus and the calreticulin receptor [96]. The dual roles of lectins are indicative
of the arms race between the virus and the host immune system, as is also observed for various viral
pathogens in humans [121]. Members of the complement system have also been shown to interact with
WSSV proteins. In the signal crayfish Pacifastacus leniusculus the surface receptor for C1q (a component
of the complement system) can interact with WSSV proteins VP15, VP26, and VP28 [92] and this is
upregulated upon WSSV infection, producing a protective effect.
After binding to receptors on the cell surface, the enveloped virus can either penetrate the
membrane directly or undergo uptake through endocytosis. Since there are several routes of
endocytosis it is useful to identify which of these may be adopted by WSSV, if any. Several
experiments have investigated WSSV endocytosis and the results depend, at least in part, on cell type.
Huang et al. [101] showed that WSSV can enter hemocytes of L. vannamei in primary culture
through caveolar endocytosis. The evidence for this included inhibition of WSSV uptake under
methyl-β-cyclodextrin (MβCD, an inhibitor of caveolar endocytosis) treatment and a lack of effect
of chlorpromazine (CPZ, an inhibitor of Clathrin-mediated endocytosis) [122]. There were similar
findings in the crayfish, Cherax quadricarinatus [123]. However, in crayfish hematopoietic tissue (HPT)
it appears to be the Clathrin-mediated endocytosis pathway that is responsible for viral uptake [124].
For this tissue, CPZ significantly inhibited WSSV internalization. Furthermore, WSSV particles
co-localized with Clathrin and there was a dependence on membrane cholesterol and dynamin
supported uptake, indicating Clathrin-mediated endocytosis. It is difficult to reconcile this apparent
contradiction in uptake pathways; however, Huang et al. [124] point to data suggesting that MβCD
also affects Clathrin-mediated endocytosis and further suggesting that WSSV could employ more than
one endocytosis pathway for host entry.
3.2. Escaping from Endosomes
After penetrating the cellular membrane, WSSV particles become localized within early
endosomes. Cellular cargo carried by endocytic vesicles can have a variety of different destinations in
the cell depending on the sorting that occurs in the early endosome [125]. Some proteins or lipids are
recycled to the plasma membranes, while others are degraded in lysosomes. Viruses need to avoid
this fate. The sorting process occurs within minutes of vesicular entry into the cell. Due to their size,
viruses are sorted by the host to the degradation pathway [126]. In completing their primary roles in
sorting the endocytotic cargo, early endosomes “mature” in a process that includes several changes
to the organelles including lumen acidification, their movement toward the perinuclear region, and
changes in membrane lipid/protein composition. It is this maturation process that provides the cue for
viruses to initiate their escape from the endosomes, which involves conformational changes of viral
proteins in response to a lower pH. Escape from the endosomes can occur either through membrane
fusion or lysis/leakage of the endosomal compartments [127]. After release from the endosomes the
virus directs itself to the nucleus and penetrates the nuclear envelope. The pathways adopted to
accomplish this by various virus families are reviewed by Kobiler et al. [128], the main difference being
whether the nuclear pore complex (NPC) is involved or not.
An important class of regulatory proteins in endocytosis are the small Rab GTPases. Rab GTPases
are key regulators of endosome maturation. Early endosomes are characterized by the presence of
Rab5 on their membranes [129]. During the endosome maturation process Rab5 is exchanged for
Rab7, the Rab GTPase associated with late endosomes, and this operates in a positive feedback loop
mechanism [130]. Rab7 can subsequently associate with RAB effector proteins like RILP that bind
Dynein, ensuring movement of the vesicle to the perinuclear area [129].
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The Rab GTPases have been implicated in the WSSV infection process. In P. monodon Rab7
(PmRab7) has been shown to interact with WSSV protein VP28 [103]. Moreover it has been shown
that in shrimp injected with WSSV and PmRab7, or PmRab7 antibody, there is a decreased rate in
mortality to 15% and 5%, respectively, compared with a mortality rate of 95% in animals injected with
WSSV alone [103]. In L. vannamei brood stock, dsRNA-mediated silencing of lvRab7 has also been
shown to reduce mortality rates, albeit a mild reduction [131]. Similarly, in P. monodon silencing of
both viral ribonucleotide reductase small subunit (rr2) and host Rab7 resulted in a 95% survival of
infected animals compared with 100% mortality in animals treated with WSSV only [132,133]. It is
unclear how the interaction between VP28 and Rab7 is mediated as the proteins are separated by
the endosomal membrane. It is possible that this interaction occurs after WSSV has been released
from the endosomes, but this can occur only if its envelope containing VP28 remains attached to the
nucleocapsid. Alternatively, the Rab proteins could be present on the cell surface [103]. Applying
subtractive hybridization, the amplification of only differentially expressed genes has shown that a
Rab GTPase gene was upregulated in the hepatopancreas of WSSV-resistant P. japonicus [134]. This Rab
GTPase gene showed homology with Rab6A, a protein involved in transport between the endosomes,
Golgi, and endoplasmic reticulum [135]. It is possible that a higher expression of Rab6A leads to an
increase in recycling of endosomes, removing the potential for WSSV to interact with Rab7, which in
turn inhibits infection and thereby leads to resistance.
Overall, the mechanisms through which WSSV reaches the nucleus after its initial uptake by
caveolar-mediated endocytosis remain poorly understood. Since the journey from the endosomes
to nucleus is a limiting step in the infection process for many viruses, a greater knowledge of this
pathway for WSSV is likely to help identify targets for drug development for disease prevention [128].
3.3. Viral Replication—The Molecular Processes
Once inside the host nucleus the virus has to express its own genes to allow for its own replication.
Since WSSV does not carry its own transcriptional machinery, it relies initially on the host to supply
these. Host transcription factors can bind to viral promoters and activate transcription. Genes
expressed this way are typically named immediate early genes. These genes encode transcription
factors and other regulators that enable transcription of viral genes. Genes dependent on the expression
of the immediate early genes are classified as “early genes”. So-called “late genes” are expressed
after initiation of viral DNA synthesis and typically include structural proteins [47]. A list of known
interactions between host proteins and viral genes is provided in Table 2.
Table 2. Established WSSV–host gene expression interactions.
Transcription Factor
(Host, Virus) Target (Host, Virus) Species Reference
STAT (PmSTAT) ie1 Penaeus monodon [136]
PHB2 (Sf-PHB2) ie1 Spodoptera frugiperda [137]
Nf-κB (LvRelish, LvDorsal) ie1, WSSV303, WSSV371 Litopenaeus Vannamei [138–140]
c-JUN ie1 L. vannamei [141] (Bioinformaticprediction)
XBP1 (LvXBP1) wsv083 L. vannamei [142]
ATF4 (LvATF4) wsv023 L. vannamei [142]
KLF (PmKLF) WSSV108 P. monodon [143]
ATFβ (LvATFβ) wsv059, wsv166 L. vannamei [144]
VP38, VP41B Caspase (PjCaspase) M. japonicus [145]
WSSV-miR-N24 Caspase 8 M. japonicus [78]
Viral protein/gene/miRNA is underlined.
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Immediate early genes expressed upon WSSV infection have been identified in infected crayfish
hemocytes via the use of a protein synthesis inhibitor, cycloheximide (CHX) [146]. Inhibiting protein
synthesis disables the ability of WSSV to create its own transcription factors and thus relies solely
on host factors. Using this approach a total of 16 ORFs have been identified including WSV069
(IE1), WSV051, WSV100, WSV079 with transactivation activity, WSV083 with Ser/Thr kinase domain,
and WSV249, believed to function as an ubiquitin E3 ligase [146]. In the Taiwan isolate of WSSV
three WSSV ORFs (WSSV126, WSSV242, and WSSV418) have been identified that were insensitive to
CHX treatment and were subsequently named immediate early 1 (ie1), ie2, and ie3, respectively [147].
Further experiments established that the promoter of ie1 could express EGFP in the fall army
worm, Spodoptera frugiperda, Sf9 cells indicating that ie1 can be activated even by non-decapod host
transcription factors. Other work has shown that the ie1 promoter of WSSV is one of the most inducible
promoters in insect cells [148] and can regulate the expression of genes in mammalian cells also [149].
It has been suggested that the broad expression capabilities of ie1 are a reason for the wide host
range of WSSV [147]. Characterization of this promoter has revealed that ie1 contains an initiator
element, TATA-box, and a binding site for the transcription factor Sp1 [137]. Activation studies of the
ie1 promoter in natural hosts of WSSV have shown that it can be activated by various host factors.
In P. monodon, STAT (PmSTAT) can increase the activity of the ie1 promoter through a STAT-binding
motif [136]. Interestingly, STAT is part of the JAK-STAT anti-viral signaling pathway, indicating
that WSSV can hijack the host immune response in order to promote expression of its own genes.
Knockdown experiments of a cytokine receptor that activates the JAK-STAT pathway in L. vannamei
(LvDOME) resulted in lower cumulative mortality and fewer WSSV copies, providing further evidence
for the interaction between JAK-STAT and WSSV [150].
In addition to STAT, WSSV can hijack other immune-related pathways, notably Nuclear Factor-κ-B
(NF-κB) signaling and MAP kinase signaling. NF-κB is a key regulator of the immune response and
important for cell survival [151]. The ie1 promoter contains a binding site for the NF-κB family
of proteins [139]. In L. vannamei a homologue of NF-κB, LvRelish, can bind to the putative NF-κB
binding site in the ie1 promoter [139]. Other in vivo experiments confirm that NF-κB homologues
lvDorsal and LvRelish can stimulate the expression of WSSV genes (e.g., WSSV069, WSSV303, and
WSSV371) through interaction with ie1 [140]. Furthermore, the expression of these transcription factors
is upregulated upon WSSV infection [138,140]. The WSSV genome also encodes a protein (WSSV449)
that shows similar functionality to Tube, a component of the NF-κB pathway. WSSV449 activates the
host NF-κB pathway and through that system promotes expression of viral genes. WSSV, as for many
other viruses (e.g., HIV-1 and hepatitis B), thus employs the NF-κB pathway for its own benefit [138].
The MAP kinase c-Jun N-terminal kinase (JNK) also has an ability to bind the ie1 promoter, implicating
involvement of MAP kinase signaling in WSSV gene expression. In L. vannamei, silencing of LvJNK with
dsRNA resulted in decreased viral proliferation, and specific MAP kinase inhibitors delay viral gene
expression [141]. A potential binding site for c-JUN has been identified in the ie1 promoter via sequence
similarity to c-JUN binding sites in TRANSFAC, a database of eukaryotic transcription factors and their
binding sites. However, transcription factor binding has yet to be validated experimentally [141,152].
After expression of ie1, WSSV IE1 protein (a viral transcription factor) is then able to facilitate expression
of the viral early genes. WSSV IE1 has been shown to accomplish this through cooperation with
P. monodon TATA box-binding proteins (PmTBP) in transcription initiation [116].
WSSV108 (a probable transcription factor/activator and/or regulator through SUMOylation)
is another WSSV immediate early gene [153]. Liu et al. [143] used the transcription factor binding
site databases TRANSFAC and JASPAR to identify regulatory elements upstream of WSSV108, and
found elements for Sp1/KLF, GATA-1, C/EBP, c-Myc, and AP-1. Furthermore, it was confirmed that
recombinant Krüppel-like factor from P. monodon (rPmKLF) could bind to the KLF element and that a
deletion in this element had the largest impact on expression through the WSSV108 promoter [143].
The action of these transcription factors result in a higher expression level of the WSSV108 promoter
than ie1 [143,146,153].
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Expression of genes in the different phases of the infection process for WSSV has been reviewed
previously by Sánchez-Paz [47]. Briefly, the genes can be grouped according to their function and they
comprise of at least three classes: transcription factors, kinases, and ubiquitin E3 ligases [47]. Early
phase genes target replication of the viral genome and include DNA polymerases, DNA helicases, and
genes involved in nucleic acid metabolism [47]. After genome replication the functional characteristics
of expressed genes shifts to structural proteins and to particle assembly during the late phase [47].
Different viruses exploit different phases of the host cell cycle for viral genome replication. Some
arrest cells in G0, G1, or at the G1/S boundary so host DNA replication is prevented, whereas others
tend to favor the S-phase where host DNA replication machinery is widely available [117]. Those that
arrest host cells in G0/G1/G1/S, which include the herpes simplex virus and Epstein–Barr virus, often
carry DNA replication machinery in their genomes instead of relying on the host [117,154,155]. WSSV
appears to operate in the S-phase and depend on host factors for replication. Viruses often control the
host cell cycle through interactions with proteins of the retinoblastoma (Rb) family, which are central
regulators of the cell cycle, operating through interaction with E2F transcription factors [117]. WSSV
IE1 and WSV056 (two paralogue genes) have been shown to be able to bind to an Rb-homologue
in L. vannamei (lv-RBL), thereby possibly activating E2F1 and leading to S-phase entry. Indeed,
overexpression of these two viral proteins in Drosophila S2 cells resulted in an increased portion of
S-phase cells and a correlated decrease in G0/G1-phase cells [117]. The authors deduced that although
WSSV carries some DNA replication machinery, it still relies on host factors; they therefore propose
that WSSV utilizes the DNA replication machinery present in host cells during S-phase and promotes
S-phase arrest to support successful replication of the viral genome.
Examples of host factors required for efficient replication are processivity factors. Processivity is
the ability to catalyze consecutive reactions without releasing the substrate. While the DNA polymerase
encoded in the WSSV genome (WSV514, [156]) shows polymerase activity [157], the average number
of nucleotides added per DNA association event has been shown to be low [157]. Usually, processivity
of DNA polymerases is improved by association with processivity factors, e.g., DNA clamps. WSSV
does not encode its own processivity factors, which indicates that WSSV DNA polymerase might
employ host processivity factors. Interaction of DNA polymerases with processivity factors occurs
through a PIP-box motif. This motif is present on WSSV DNA polymerase [157]. To investigate the
possibility of interaction with a host processivity factor in L. vannamei, the 3D structure of Proliferating
Cell Nuclear Antigen (LvPCNA) was elucidated [104,158]. Likely PIP-box interaction models between
LvPCNA and WSSV DNA polymerase were established but have yet to be confirmed experimentally.
3.4. Maintaining the Host Cell Environment
The presence of a virus within a host cell places demands on that cell, e.g., through draws on
energy for anabolic reactions, demand for essential nutrients, and accumulation of non-host proteins.
Such impacts on the cell lead to a deterioration of the cellular environment, making it less conducive for
viral replication. Host cells also have evolved mechanisms to reduce the ability of viruses to replicate,
for example through withholding nutrients in cases of infection or inhibiting translation. The cell might
enter apoptosis, preventing further viral replication by undergoing self-destruction. To counteract
these adverse cellular responses, viruses have evolved ways to interact with host metabolism, stress
response systems, and apoptosis signaling for the purpose of retaining an appropriate environment
for replication. Some of these interactions have been investigated for WSSV infections, but the limited
understanding of the function of many WSSV proteins limits interpretation for some of the effects
identified (Figure 2).
3.4.1. Metabolism
The replication of the viral genome and synthesis of its structural components require a large
amount of energy. To supply the cell with such large quantities of energy, host metabolism can be
directed to induce aerobic glycolysis [159]. Often observed in cells during rapid proliferation, a high
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rate of glycolysis provides both energy and glycolytic intermediates that can be used in a variety of
anabolic reactions [159]. This metabolic shift was originally described in cancer cells and is known as
the Warburg effect [160]. The Warburg effect also encompasses enhancement of the pentose phosphate
pathway, amino acid metabolism, and lipid homeostasis [161]. Induction of a Warburg-like effect by
WSSV infection has been observed in L. vannamei hemocytes [162]. In a study by Su et al. [139], it was
established that the PI3K-Akt-mTOR pathway was the mechanism through which metabolic changes
where induced by WSSV. PI3K-Akt-mTOR is also employed by cancer cells and human papillomavirus
to induce the Warburg effect [161,163,164]. However, the viral factors that interact with the host
PI3K-Akt-mTOR pathway have yet to be identified.
3.4.2. Iron
In addition to energy, WSSV and other invading pathogens also require essential nutrients
including iron. In response to this, hosts have evolved mechanisms through which they can withhold
iron from pathogens, thereby inhibiting their proliferation. The protein responsible for this mechanism
is ferritin [105]. The ferritin defense mechanism has been demonstrated in L. vannamei, where its
injection reduced susceptibility to WSSV infection. Higher amounts of ferritin resulted in a greater
binding of iron and thus less iron available for WSSV proliferation. Conversely, dsRNA-mediated
knockdown of ferritin resulted in a three-fold increase in viral copy number [165]. Through the use of
a yeast two-hybrid experiment, it has been shown that WSSV protein kinase 1 (WSSV PK1) can interact
with host ferritin and influence the availability of iron [105]. Binding of WSSV PK1 does not release
iron from ferritin but rather prevents iron from binding to apoferritin (ferritin without bound iron).
Injection of dsRNA specific to WSSV PK1 decreases cumulative mortality, showing that disrupting
host iron withholding mechanisms is important to successful WSSV infection [166].
3.4.3. Endoplasmic Reticulum Stress Responses
The presence of a virus within the cell can induce the unfolded protein response (UPR), a cellular
stress response activated because of accumulation of misfolded protein at the ER. This leads to
phosphorylation of transmembrane kinases and activation of transcription factors. Outputs of the
UPR include global translation shutdown, arrest of cell cycle, increase in expression of chaperone
genes to aid in protein folding, and potentially apoptosis [167]. While increased folding capabilities
can aid the virus, translation attenuation and apoptosis have adverse effects on viral replication [168].
Therefore many viruses have evolved mechanisms through which the host UPR response can be
manipulated [169].
There are three pathways that can initiate the UPR response, namely via Inositol-requiring
enzyme-1 to X-box binding protein 1 (IRE1-XBP1), via double-stranded RNA-activated Protein
kinase-like ER kinase and Activating Transcription Factor 4 (PERK-ATF4), and via Activating
Transcription Factor 6 (ATF6). Interactions between viruses and these UPR pathways are complex,
as some viruses inhibit responses whereas others induce them. For example, the Epstein–Barr virus
(EBV) induces UPR to aid in lytic replication [170], Rotavirus induces and controls UPR to prevent ER
stress-related cell death [171], and Herpes simplex virus-1 inhibits UPR to maintain an environment
that permits expression of viral genes [172,173].
Interactions between WSSV and UPR in shrimp have been demonstrated through studies
on the expression of chaperone proteins [174–178]. Induction of the IRE1-XBP1 UPR pathway
upon WSSV infection in L. vannamei has been shown through enhanced expression of LvXBP1.
Furthermore, WSSV appears to benefit from its induction, as demonstrated by lower cumulative
mortality following dsRNA-mediated knockdown of LvXBP1 [173]. A potential mechanism for this
effect is LvXBP1-mediated upregulation of expression of the viral gene wsv083, a predicted protein
kinase 2, and wsv023, of unknown function [49,142]. Wsv083 has been shown to inhibit focal adhesion
kinase, a regulator of innate immune system signaling [106,142]. The transcription factors of the
PREK-ATF4 pathway can also induce expression of WSSV genes, depending on the presence of an
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ATF/CRE in the promoter (15 in total: wsv023, wsv049, wsv064, wsv069, wsv138, wsv242, wsv256, wsv282,
wsv303, wsv306, wsv313, wsv321, wsv343, wsv406, and wsv453). In L. vannamei the UPR transcription
factor LvATF4 (as for LvXBP1) also upregulates expression of wsv023 [142].
The shutdown of translation following UPR activation is achieved through phosphorylation
of the translation initiation factor subunit eIF2α [179]. Phosphorylated eIF2α inhibits activation of
eIF2 by preventing the exchange of GDP for GTP by its eIF2β subunit. During WSSV infection in
L. vannamei the level of LveIF2α decreases and the phosphorylation ratio increases, suggesting that the
virus indeed initiates eIF2α-mediated translation inhibition [180]. Furthermore, adding an inhibitor
of eIF2α phosphatases decreases viral loads, indicating that WSSV requires active eIF2 for successful
replication. Xu et al. [180] suggest that WSSV could code for proteins able to prevent phosphorylation
of eIF2α, thereby halting UPR initiated translation inhibition, a strategy that is also observed in the
Chikungunya virus. In summary, data to date suggest that the presence of WSSV induces the UPR
and is capable of interacting with downstream effectors and transcription factors activated through
the UPR. These processes aid in the transcription of viral genes. However, limited knowledge of viral
protein function limits our current understanding on the roles of these viral genes.
3.4.4. Apoptosis
Cellular responses to stress can result in the induction of apoptosis of the host cell. Through
apoptosis organisms can remove cells that are potentially harmful to their own health. Apoptosis is
an important defense mechanism against abnormalities in cell programming and disease infection,
including viruses. The relationship between virus and apoptosis is complex and viruses can influence
the host apoptosis system by either inhibiting or inducing it. Inhibition is necessary to keep a cellular
environment conducive to the production of new virions [181]. In later stages of viral infection,
however, some viruses might induce apoptosis as a means of leaving cells and spreading further
throughout the host [182]. Apoptosis has been documented to occur in L. vannamei, P. monodon,
and M. japonicus cells infected with WSSV [183–186]. Leu et al. [187] proposed a detailed model
for the apoptotic interaction between WSSV and shrimp, in which invasion of WSSV leads to
activation of signaling pathways that increase expression of pro-apoptosis proteins (e.g., Caspases
and voltage-dependent anion channels), membrane permeabilization of mitochondria, and increased
oxidative stress. These molecular pathways lead to the initiation of the apoptosis program. In parallel,
WSSV anti-apoptotic proteins attempt to block apoptosis and thereby keep the cell viable for replication.
The balance between the pro- and anti-apoptosis activation processes will determine the fate of the
WSSV-infected cell [187].
Caspases are key regulators of apoptosis and therefore important targets for viruses. The family
can be generally grouped into initiator caspases and effector caspases. The first are activated through
autocatalytic processes, whereas the latter are present as zymogens activated through cleavage by the
initiator caspases [188]. Activation of effector caspases leads to an accelerated feedback loop of effector
caspase activation and eventually permits the controlled destruction of cellular components [189].
WSSV proteins show interactions with shrimp caspases. Direct inhibition of the activity of a P. monodon
effector caspase (PmCaspase) by the WSSV protein anti-apoptosis protein 1 (AAP1 or WSSV449) has
been shown in Sf9 cells [107]. AAP1 binds to, and is cleaved by, PmCaspase at two possible sites,
with only one resulting in PmCaspase inhibition [107]. In a similar cellular system another effector
caspase in P. monodon, PmCasp, can be bound by viral proteins WSSV134 and WSSV322, resulting
in anti-apoptotic activity [108]. However, inhibition of PmCasp by AAP1 and WSSV449 does not
occur, illustrating the diversity of effector caspases and their activity [108]. A different method of host
caspase regulation has been revealed in M. japonicus. Here, the caspase gene PjCaspase was identified
and shown to be upregulated in survivors of WSD [190]. Silencing of this gene resulted in inhibition
of apoptosis, and the subsequent increase in viral copy number showed that induction of apoptosis
in infected cells is beneficial to the host. Zuo et al. [145] have also shown that WSSV can regulate the
expression of caspase. Viral proteins VP38 (WSV259) and VP41B (WSV242) were capable of binding
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the PjCaspase promoter, the first acting as a repressor and the latter acting as an activator. Interestingly,
both of these WSSV proteins are envelope proteins: VP41B having a potential transmembrane domain
and VP38 through association with envelope protein VP24 [191,192]. The capability of WSSV to both
repress and promote caspase genes follows the observation that some viruses induce apoptosis to
facilitate departure from the host cell.
Yet another route through which WSSV can induce apoptosis is through ubiquitination, a process
by which attachment of ubiquitin to a protein can flag it for degradation in proteasomes. This
mechanism plays an important role in regulation of apoptosis as many substrates of ubiquitination
are regulatory proteins for apoptosis [193]. Ubiquitin is activated by an ubiquitin-activating enzyme
(E1), subsequently transferred to a ubiquitin-conjugating enzyme (E2) and, through interaction with
an E3-ligase, transferred to the target protein [194]. WSSV249 has been shown to be involved in
ubiquitination by acting as an E3-ligase in cooperation with the conjugating enzyme PvUbc in
L. vannamei [109]. This WSSV249 interaction is accomplished through its RING-H2 domain, a domain
associated with E3-ligases [46,195]. RING domains are present in four WSSV proteins, namely
WSSV199, WSSV222, WSSV249, and WSSV403 [109,196]. The RING-H2 domain of WSSV222 enables it
to perform as an E3-ligase in the ubiquitination of tumor suppressor-like protein, thereby inhibiting
apoptosis [197]. Whether any of the other RING domain containing proteins have apoptosis inhibiting
function remains to be determined. Together with caspase inhibition, the success of ubiquitination of
pro-apoptotic proteins will determine the fate of the host cell [187].
Wang et al. [110,198] have suggested a third virus–host interaction that could influence the
apoptotic state of the host cell, involving the highly expressed WSSV protein ICP11. The crystal
structure of dimers of ICP11 indicates that it could act as a DNA mimic [110]. The electrostatic surface
of ICP11 shows patches of negatively charged amino acids that are arranged in two rows and at similar
distances as dsDNA phosphate groups [110]. Furthermore, it was shown that ICP11 could interfere
with the binding of host DNA to histones (H3) in HeLa cells [110]. This binding can lead to disruption
of the host nucleosome assembly and even apoptosis [110]. An alternative crystal structure of the
dimer of VP9 (ICP11) has been proposed that does not show such rows of negative charges [199].
Instead, VP9 shows structural folds that bear resemblance to E2, a transcription/replication factor of
the human papillomavirus [111,200]. In P. monodon it has been shown that VP9 can interact with a
receptor for activated protein kinase C1 (PmRACK1), using the yeast two-hybrid and GST pulldown
assay, [111]. Mammalian RACK1 receptors are involved in a large variety of functions including cell
signaling pathways, cell development, and the immune response, and can interact with a large number
of viral proteins [111]. The interaction between these two proteins may be involved in intracellular
VP9 functions, for example by transporting VP9 to the nucleus [111].
3.4.5. Particle Assembly and Release
After replication of the viral genome and production of structural proteins, these components
come together to be assembled into new virions. One of the most challenging aspects of viral particle
assembly is packaging the WSSV 300 kb genome into the nucleocapsid. In eukaryotes, DNA is
compacted in nucleosomes but this does not occur in viruses. In dsDNA viruses, DNA packaging
is often accomplished through interactions between DNA and nucleocapsid proteins [201]. A small
(6.7 kDa) viral protein, VP15, has been associated with WSSV DNA packaging. VP15 is a basic
protein that shows homology to putative baculovirus DNA-binding proteins [202]. Studies have
shown that VP15 can form homomultimers and is able to bind to (preferably supercoiled) DNA [202].
Application of Atomic Force Microscopy has shown that VP15 is able to condense DNA and that
VP15-induced DNA condensates resemble packaged viral DNA [201]. In the packaging process
VP15 can interact with host proteins. In P. monodon binding has been shown between VP15 and
PmFKBP46, an immunophilins-like protein [112]. The role of PmFKBP46 in P. monodon is not known
but human and yeast homologues are involved in histone deacetylation and act as a histone chaperone,
respectively [112,203,204]. A more recent study uncovered an interaction between VP15 and calreticulin
Viruses 2016, 8, 23 16 of 29
(CRT), which could also act as a histone chaperone [101,205]. DsRNA-mediated knockdown of CRT
resulted in a significant decrease in viral DNA duplication and viral gene transcription, indicating that
the interaction between CRT and VP15 is necessary for viral replication. It has also been suggested that
the interaction between VP15 and CRT can play a role in the export of viral RNA from the nucleus, a
role that CRT has been shown to fulfill for glucocorticoid receptors [101,206].
Morphogenesis of the WSSV envelope requires long chain fatty acids (LCFA). During the early
stages of infection fatty acids in the host cell are depleted in order to generate the energy required
for viral replication, but during the late stage of infection LCFAs are upregulated, thus replenishing
the LCFA that have been used [207]. Applying an inhibitor of fatty acid synthase (FAS) that blocked
the replenishment of LCFA was shown to result in impaired virion formation [207]. There is little
information available on how assembled WSSV virions are subsequently released from the host cell.
4. Current Treatment Options for WSD
Despite the large body of work, our understanding of WSSV infection and pathogenesis are far
from complete. Unresolved questions include those focused on mechanisms of endosomal escape,
virion assembly, exit from the host cell, and the role of miRNA regulation. Nevertheless, because of the
urgent need for disease mitigation (and prevention) avenues have been explored for potential therapy.
Here we discuss some of the more promising results that include strategies spanning immune system
activation, vaccinations, RNAi, and the application of herbal extracts.
Early studies investigated whether WSD could be prevented by enhancing immune competence
of the host. This can be achieved by feeding with agents containing pathogen-associated molecular
patterns (PAMP) that are known to activate the host innate immune system. It was found that
feeding P. japonicus with peptidoglycans over a period of time increased the phagocytic activity
of host granulocytes, resulting in a significant decrease in mortality upon WSSV exposure [208].
Similarly, injection of β-glucan prior to WSSV infection has been shown to result in activation of the
prophenoloxidase system and subsequently a reduction of mortality (25%–50% as compared to 100%
in controls). However, repeated dosages of β-glucan cause high mortality rates in the host, which is
probably due to excess generation of reactive oxygen species [209].
Invertebrates do not possess an adaptive immune system and they thus rely on innate immune
defenses. As a consequence, it is not possible to develop vaccines in the traditional way as is done in
mammals and other vertebrates. However, recent developments have provided evidence that certain
forms of pathogen-specific “immune priming” are possible in some invertebrates [210]. For example,
short-term protection against WSSV can be achieved through exposing shrimp to inactivated viral
particles [211]. Musthaq and Kwang reviewed the possibilities of such vaccinations for WSD and the
types of treatments (vaccines) that can provide temporal protection against WSD [210]. These include
inactivated virus, recombinant viral proteins, viral DNA, and double-stranded RNA, and often involve
WSSV envelope proteins like VP28 because of their importance to the infection process. However,
all of these treatments provide temporal protection that does not usually last beyond 14 days. New
generation technologies are attempting to provide more efficient delivery systems for these treatments.
For example, baculovirus and Bacillus subtilis spores, both modified to express VP28, could convey
protection via oral vaccination [212,213]. Elucidation of the mechanisms underlying invertebrate
immune priming could lead to further gains in vaccine efficacy and provide an optimized solution.
RNAi can potentially play a significant part in host–pathogen interactions. Hosts can express
small RNA molecules that target and inhibit the expression of viral proteins. It has been shown that
M. japonicus can generate small interfering RNA (siRNA) that targets vp28 (vp28-siRNA) in response to
infection by WSSV. Blocking siRNA synthesis resulted in increased viral copy numbers, indicating
that RNAi had a protective effect for the host [214]. In other work vp28-siRNAs encapsulated with
β-1,3-D-glucan and injected along with WSSV in M. japonicus [215] was shown to inhibit WSSV
replication, illustrating a potential avenue for treatment development.
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Another direction of research focused on combating WSD has been the utilization of plant extracts
with potential pharmaceutical activity. Large screens with extracts from plants have been carried
out in an attempt to identify chemicals with anti-WSSV properties and there have been a number
of successes. Examples include extracts of Cynodon dactylon and Ceriops tagal [216,217] that have
shown protective effects against WSSV in P. monodon. Extracts from the seaweed Sagrassum weighti
have been shown to have a significant effect in reducing WSSV infection in both the Indian prawn
(P. indicus) and freshwater crab (Paratelphusa hydrodomous) [218,219]. Oral administration of a plant
extract from Momordica charantia has been shown to result in an 86% survivorship in L. vannamei
infected with WSSV [219]. Furthermore, several diets based on extracts from Agathi grandiflora have
also been shown to decrease mortality rates substantially in WSSV-infected Fenneropenaeus indicus [220].
The nature of the pharmaceutically active components of these extracts, and how they interact with
host and virus, is unknown for the treatments described. Filling these knowledge gaps could result in
a better understanding of WSSV infection and aid in optimizing efficacy in the use of these materials
in preventing WSD.
5. Future Perspectives
In recent years WSD has received significant scientific attention, driven by the commercial impacts
of this disease on shrimp. Global research efforts into understanding the biology of WSSV and infection
process for WSD have contributed to the formulation of strategies for disease treatment and prevention.
Molecular studies have identified a substantial number of WSSV envelope and cell surface proteins
involved in the first stage of virus infection, established a large number of host transcription factors
replication of WSSV, and established some of the mechanisms by which the virus maintains a favorable
host cell environment including through arresting the cell cycle, changing metabolism, and preventing
apoptosis. Major gaps, however, remain in our understanding of how the virus, upon entering the
host cell via endosomes, subsequently delivers its genome to the host nucleus, the virion assembly
process, and in fact the function of the majority of WSSV proteins.
Research on WSD infection has been complicated by the lack of well-annotated genomic resources
for host species. There has been a reliance placed on sequence similarities with other (sequenced)
species to provide required annotation. Sequence information for aquatic crustaceans, however, is
extremely limited. Application of modern sequencing technologies now allows for relatively rapid
generation of the required sequence information to support both de novo genome assemblies and for
transcriptome analyses, and this work needs to be encouraged to provide the required molecular
resources for commercially important species as a minimum. Current research on WSSV infection has
focused overwhelmingly on susceptible shrimp species, which is not surprising given their economic
importance, but opportunities could lie in studies on more resistant (and perhaps less popular) host
organisms. Understanding how those organisms resist WSD could equally lead to effective disease
treatments for shrimp.
Understanding the WSSV infection process completely may not be necessary in order to produce
effective therapeutics. Current knowledge provides a plethora of potential pathways/genes/miRNAs
that could serve as potential treatment targets and indeed there has been some success in applying
targeted molecular approaches in the treatment of WSD. To date, however, these treatments applied in
a laboratory context have not been successfully applied in the field. As an example, RNAi has shown
great potential as therapeutic technology and indeed VP28-siRNA has been shown to be effective
against WSSV. However, it requires delivery through injections, which is not viable for commercial
application. The development of an effective delivery method for siRNA that can be used in shrimp
farms would be a significant step forward in the prevention of WSD and would also have great
potential for use in the treatment of other viruses that impact aquatic Crustacea. Other prospects
include production of genetically modified shrimp for resistance to WSD, for example by enhancing
anti-WSSV RNAi.
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Another potential avenue for exploration in combating WSD relates to resistance that has
developed in certain hosts through integration of viral DNA into the host genome, conveying resistance
to the inserted virus (and sometimes also closely related pathogens). If such a mechanism of resistance
could be transferred from resistant to susceptible shrimp species, this could result in the production of
shrimp lines that are resistant to WSSV.
Bringing this review to a close, we would emphasize that while understanding the molecular
basis of WSD is likely to lead to possible intervention strategies for combating WSD, the practical
implementation of this knowledge, given the nature of the shrimp farming industry, will require the
resulting treatments to be cheap, easy to use, and easily distributed. It should also be recognized
that there are many other factors that need due consideration in our attempts to develop improved
treatments for, and to combat, WSD. For example, it is the case that outbreaks of WSD in farming will
inevitably depend on the health status of host organisms and the environments in which they live
and this is not necessarily determined by individual pathogens alone but by a combination of local
abiotic and biotic factors, pathogen assemblages, and pathogen loads in host tissues. Almost nothing
is yet known in this regard for WSD. Indeed, WSSV may be endemic in aquaculture and may only
occur under certain conditions. Identifying those conditions and the biological indicators associated
with health status and disease outbreaks in shrimp aquaculture ponds could help in predicting and
pre-empting WSD outbreaks, allowing for intervention strategies, and uncoupling the ability of WSSV
to interact with its host. More effective and intelligent surveillance systems for preventing the spread
of WSD outbreaks are also a major research need.
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